|Phase of Study:||Phase II|
|Treatment Location:||Only at MDACC|
|Estimated Length of Stay in Houston:||Patients may require hospitalizations of up to 5 days for clofarabine. |
Hospitalization is not mandatory and outpatient administration of chemothearpy
|Return Visit:||Patients will return to MD Anderson Cancer Center prior to each course.|
|Home Care:||Therapy will be administered either at MDACC or outside MDACC as allowed and |
approved by the principal investigator. Patients may be followed locally in
between therapies for blood work and supportive care.